A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/08 (2006.01) A61K 38/17 (2006.01) C07K 14/73 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2102606
The present invention relates to a method of treating chronic fatigue syndrome not associated with an HIV infection. In the method of the present invention patients are administered a pharmaceutically acceptable carrier together with (1) a neuropsychi- atrically effective amount of a linear peptide of formula (I): R a-Ser-Thr-Thr- Thr-Asn-Tyr-R6, wherein R a is Ala, D-Ala or Cys- Ala-, and R6 is Thr, Thr-amide, Thr-Cys or Thr-Cys-amide, or a derivative of the peptide or a physiologically acceptable salt thereof; or (2) a neuropsychiatrically effective amount of a linear peptide of formula (II): R1-R2-R3-R4-R5, wherein R1 is X- Y or Y when Y is Thr-, Ser-, Asn-, Leu-, Ile-, Arg- or Glu-, and X is Cys; R2 is Thr-, Ser- or Asp; R3 is Thr, Slr, Asn, Arg, Gln, Lys or Trp; R4 is Tyr; and R5 is Z-X or Z wherein Z is an amino acid and X is Cys, or a derivative of the peptide or a physiologically acceptable salt thereof; or (3) a neuropsychiatrically effective amount of a linear peptide of formula (III): R x-R2-R3-R4-R y, wherein R x is Ala-R1, D-Ala-R1 or X-Ala-R1 wherein X, R1, R2, R3, R4 are as defined above, and R y is Thr-, Thr-amide or Thr-Cys, or a derivative of the petide or a physiologically acceptable salt thereof.
Bridge Thomas P.
Goodwin Frederick K.
Department O. F. Health And Human Services The United States Of America Represented By The Secretary
Smart & Biggar
LandOfFree
Compositions for the treatment of chronic fatigue syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the treatment of chronic fatigue syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the treatment of chronic fatigue syndrome will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1640324